PUNCTURE SITE INJURY

PUNCTURE SITE INJURY was reported 25 times

PUNCTURE SITE INJURY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Non-Standardized Fungal Allergenic Extract [EPC] 1 0.0005
1 Non-Standardized Insect Allergenic Extract [EPC] 1 0.0002
2 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 2 0.0001
3 Standardized Insect Venom Allergenic Extract [EPC] 1 0.0001
4 Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 1 0.0001
5 Echinocandin Antifungal [EPC] 1 0.0001
6 Antisense Oligonucleotide [EPC] 1 0.0001
7 PCSK9 Inhibitor [EPC] 2 0.0001
8 Non-Standardized Plant Allergenic Extract [EPC] 1 0.0001
9 Interleukin-17A Antagonist [EPC] 2 0.0001
10 Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] 1 0.0000
11 Copper-containing Intrauterine Device [EPC] 2 0.0000
12 Aromatic Amino Acid Decarboxylation Inhibitor [EPC] 1 0.0000
13 Provitamin D2 Compound [EPC] 1 0.0000
14 Cholinergic Muscarinic Antagonist [EPC] 1 0.0000
15 beta3-Adrenergic Agonist [EPC] 1 0.0000
16 Interleukin-6 Receptor Antagonist [EPC] 2 0.0000
17 Non-Standardized Chemical Allergen [EPC] 1 0.0000
18 Non-Standardized Food Allergenic Extract [EPC] 1 0.0000
19 Catecholamine [EPC] 1 0.0000
20 Acetylcholine Release Inhibitor [EPC] 1 0.0000
21 Interleukin-23 Antagonist [EPC] 1 0.0000
22 Aromatase Inhibitor [EPC] 1 0.0000
23 Calcium [EPC] 1 0.0000
24 Janus Kinase Inhibitor [EPC] 1 0.0000
25 Interferon beta [EPC] 1 0.0000
26 Thiazide Diuretic [EPC] 1 0.0000
27 Factor Xa Inhibitor [EPC] 1 0.0000
28 Loop Diuretic [EPC] 1 0.0000
29 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
30 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
31 Benzodiazepine [EPC] 1 0.0000
32 Corticosteroid [EPC] 1 0.0000
33 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000